Shares of Elite Pharmaceuticals Inc. (OTCMKTS:ELTP – Get Free Report) gapped down before the market opened on Wednesday . The stock had previously closed at $0.4687, but opened at $0.4525. Elite Pharmaceuticals shares last traded at $0.4798, with a volume of 201,662 shares changing hands.
Elite Pharmaceuticals Trading Up 0.3%
The firm’s 50 day moving average price is $0.51 and its 200-day moving average price is $0.57. The company has a debt-to-equity ratio of 0.06, a current ratio of 8.04 and a quick ratio of 6.34. The stock has a market cap of $506.08 million, a P/E ratio of 47.04 and a beta of 0.32.
About Elite Pharmaceuticals
Elite Pharmaceuticals, Inc is a U.S.-based specialty pharmaceutical company that acquires, develops and markets both branded and generic pharmaceutical products. Headquartered in Houston, Texas, the company focuses on complex dosage forms—including injectables, sterile formulations and oncology therapies—and seeks to address unmet medical needs through advanced drug delivery technologies. Its product portfolio spans therapeutic areas such as pain management, oncology and cardiovascular care.
Since its founding in 2007, Elite Pharmaceuticals has pursued strategic partnerships and licensing agreements to expand its pipeline and manufacturing capabilities.
Featured Articles
- Five stocks we like better than Elite Pharmaceuticals
- Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!
- How a Family Trust May Be Able To Help Preserve Your Wealth
- Do not delete, read immediately
- A U.S. “birthright” claim worth trillions – activated quietly
- Refund From 1933: Trump’s Reset May Create Instant Wealth
Receive News & Ratings for Elite Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Elite Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
